BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 8, 2002
View Archived Issues
ImClone Systems and Bristol-Myers Squibb revise Erbitux agreement
Read More
Onyx and Proacta to collaborate on therapeutic virus research and development
Read More
Fujirebio Diagnostics acquires rights to develop cancer diagnostics using Survivin gene
Read More
AtheroGenics begins phase I trial of transplant rejection drug AGI-1096
Read More
Encouraging results of DCVax-Prostate in late-stage prostate cancer
Read More
Ionix and Xenome collaborate on analgesic drug discovery
Read More
Institut Pasteur to evaluate Novirio compounds for hemorrhagic fever viruses
Read More
AltaRex initiates OvaRex pharmacokinetic study
Read More
Actonel found to be equieffective in weekly or daily doses in postmenopausal women
Read More
Lundbeck drops potential anxiolytic from pipeline
Read More
Cipralex/Lexapro heads for major launches by mid-2002
Read More
Allopurinol exerts immunomodulating effects in experimental autoimmune uveitis
Read More
Once-daily ravuconazole effective and safe in Rx of onychomycosis
Read More
Safety of repinotan demonstrated in subjects with severe traumatic brain injury
Read More
European phase II pancreatic adenocarcinoma trial of investigational camptothecin derivative reports
Read More
Clinical results for efalizumab in plaque psoriasis constitute a highlight of the AAD meeting
Read More
The Medicines Company acquires rights to clevidipine
Read More
Researchers at Zentaris describe novel series of antitumor agents
Read More
CPMP recommends expansion of desloratadine indication to indoor and outdoor allergies
Read More
Additional trial requested for sNDA of Thalomid in early stage multiple myeloma
Read More
FDA finds Soltara not approvable
Read More
Thirty-six new products reach their first markets in 2001
Read More
Chugai identifies coumarin derivatives useful as TNF-alpha inhibitors
Read More
Nucleoside analogues and their use as antiviral agents reported
Read More
Compounds that inhibit cholesterol biosynthesis and their uses claimed by Boehringer Ingelheim
Read More
Lundbeck patents novel inhibitors of glycine transporters
Read More